Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

First Documentation of Cell-to-Cell Peroxisome Transfer in Hematopoietic Stem and Progenitor Cells: A Method to "Relieve Stress"?

Wilaiwan Durose, Ashish O. Gupta, Paul J. Orchard, Erin Nolan, Ashley C. Kramer, Troy C. Lund

Blood (2022) 140 (Supplement 1): 1686–1687.

https://doi.org/10.1182/blood-2022-155851

Published: 2022

Journal Articles

Bodyweight and Absolute Lymphocyte Count Based Dosing of Rabbit Anti-Thymocyte Globulin Results in Early CD4+ Immune Reconstitution in Patients with Inborn Errors of Metabolism Undergoing Umbilical Cord Blood Transplantation

Daniel Drozdov, Susie L. Long, Ashish O. Gupta, Troy C. Lund, Jaap Jan Boelens, Paul J. Orchard

Blood (2022) 140 (Supplement 1): 4797–4798.

https://doi.org/10.1182/blood-2022-158585

Published: 2022

Journal Articles

Adrenoleukodystrophy Protein (ALDP) Antibody Formation and Graft Loss in Gene Therapy for Adrenoleukodystrophy

Ashish O. Gupta, Paul J. Orchard, Stuti Thakker, Wilaiwan Durose, Carina King, Troy C. Lund

Blood (2022) 140 (Supplement 1): 10641–10642.

https://doi.org/10.1182/blood-2022-155852

Published: 2022

Journal Articles

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in Gvhd Risk without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

Blood (2022) 140 (Supplement 1): 282–283.

https://doi.org/10.1182/blood-2022-165782

Published: 2022

Journal Articles

Low Incidence of Chronic Graft-Versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Using Matched Related or Unrelated Donors: Phase II Study Interim Analysis

Blood (2021) 138 (Supplement 1): 1811.

https://doi.org/10.1182/blood-2021-147569

Published: 2021

Journal Articles

Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy

Paul J. Orchard, David R. Nascene, Weston P. Miller, Ashish Gupta, Dan Kenney-Jung, Troy C. Lund

Blood (2019) 133 (12): 1378–1381.

https://doi.org/10.1182/blood-2018-11-887240

Published: 2019

Includes: Supplemental data

Journal Articles

Preliminary Phase 2 Results Demonstrate Engraftment with Minimal Neutropenia with MGTA-456, a CD34 + Expanded Cord Blood (CB) Product in Patients Transplanted for Inherited Metabolic Disorders (IMD)

Paul Orchard, MD, Glen D. Raffel, MD, Carolyn H Condon, MPH, Catherine A Monaghan, Demetra Vernet, Suzanne Tracey Sheirr, Jennifer Braun, RN BSN, Ryan Shanley, M.S, Troy C Lund, MD MS, PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD, John C Davis, MD MPH, John E. Wagner, MD

Blood (2018) 132 (Supplement 1): 3467.

https://doi.org/10.1182/blood-2018-99-115102

Published: 2018

Journal Articles

Repair of the Blood Brain Barrier and Neutrophil Recovery Following HSCT in Cerebral Adrenoleukodystrophy

Troy C Lund, MDMS, PhD, Weston P. Miller, MD, Dave Nascene, MD, Paul Orchard, MD, Ashish O. Gupta, MBBS, MPH

Blood (2018) 132 (Supplement 1): 4628.

https://doi.org/10.1182/blood-2018-99-109801

Published: 2018

Journal Articles

HHV-6 Prophylaxis with Foscanet Improves Hematopoietic Engraftment after Umbilical Cord Blood Transplantation

Nelli Bejanyan, MD, John Rogosheske, PharmD, Todd E. DeFor, MS, Jaime Green, MD, Troy C Lund, MD PhD, Daniel J. Weisdorf, MD, John E. Wagner, MD, Claudio G Brunstein, MD PhD

Blood (2017) 130 (Supplement 1): 1951.

https://doi.org/10.1182/blood.V130.Suppl_1.1951.1951

Published: 2017

Journal Articles

Pediatric multiple myeloma

Kristin L. Pilbeam, Troy C. Lund

Blood (2017) 129 (3): 395.

https://doi.org/10.1182/blood-2016-09-741322

Published: 2017

Journal Articles

Adipogenic Chemokine Inhibition of Hematopoietic Cell Adherence and Transmigration, a Hurdle to Homing

Troy C Lund, MD PhD, Ashley C. Kramer, Paul Stadem, BS, Michael Lehrke, MS, Taylour Hanson, MS

Blood (2015) 126 (23): 782.

https://doi.org/10.1182/blood.V126.23.782.782

Published: 2015

Journal Articles

Mitochondrial Haplotype As an Independent Predictor of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT)

Julie A. Ross, PhD, Jakub Tolar, MD PhD, Logan G. Spector, PhD, Todd E. Defor, MS, Troy C. Lund, MDPhD, Daniel J. Weisdorf, MD, Anthony J. Hooten, B.S., Bharat Thyagarajan, MD PhD, Erica Langer, BS, Michelle K. Gleason, PhD, John E Wagner, MD, Kimberly Robien, PhD RD, Michael R. Verneris, MD

Blood (2014) 124 (21): 683.

https://doi.org/10.1182/blood.V124.21.683.683

Published: 2014

Journal Articles

Mutant tp53 Causes a Gain of Function Increase in Sensitivity to Reactive Oxygen Species in Erythroid Precursors

Troy C. Lund, MDPhD, Michelle L Carter, PhD, Ashley C. Kramer, Bruce R. Blazar, MD, Julie A. Ross, PhD

Blood (2014) 124 (21): 2668.

https://doi.org/10.1182/blood.V124.21.2668.2668

Published: 2014

Journal Articles

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33 + targets

Michelle K. Gleason, Julie A. Ross, Erica D. Warlick, Troy C. Lund, Michael R. Verneris, Andres Wiernik, Stephen Spellman, Michael D. Haagenson, Alexander J. Lenvik, Mark R. Litzow, Pearlie K. Epling-Burnette, Bruce R. Blazar, Louis M. Weiner, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller

Blood (2014) 123 (19): 3016–3026.

https://doi.org/10.1182/blood-2013-10-533398

Published: 2014

Includes: Supplemental data

Journal Articles

The Oxidative Stress Response In Erythroid Precursors Is Mediated By tp53

Troy C. Lund, MD/PhD, Michelle L. Carter, PhD, Ashley C. Kramer, Nardina Nash, Bruce R. Blazar, MD

Blood (2013) 122 (21): 7.

https://doi.org/10.1182/blood.V122.21.7.7

Published: 2013

Journal Articles

A Novel CD16xCD33 Bispecific Killer Cell Engager (BiKE) Mediates a Double Hit For Natural Killer (NK) Cells To Target CD33 + Myelodysplastic Syndrome (MDS) Cells and Myeloid Derived Suppressor Cells (MDSCs) At All Disease Stages

Michelle K. Gleason, PhD, Julie A. Ross, PhD, Troy C. Lund, MD/PhD, Michael R. Verneris, MD, Andres Wiernik, MD, Erica D. Warlick, MD, Stephen Spellman, MBS, Michael D. Haagenson, MS, Alexander J. Lenvik, Mark R. Litzow, MD, Daniel J. Weisdorf, MD, Daniel A. Vallera, PhD, Jeffrey S. Miller, MD

Blood (2013) 122 (21): 385.

https://doi.org/10.1182/blood.V122.21.385.385

Published: 2013

Journal Articles

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report

Weston P. Miller, Steven M. Rothman, David Nascene, Teresa Kivisto, Todd E. DeFor, Richard S. Ziegler, Julie Eisengart, Kara Leiser, Gerald Raymond, Troy C. Lund, Jakub Tolar, Paul J. Orchard

Blood (2011) 118 (7): 1971–1978.

https://doi.org/10.1182/blood-2011-01-329235

Published: 2011

Journal Articles

Stromal cell–derived factor-1 and hematopoietic cell homing in an adult zebrafish model of hematopoietic cell transplantation

Tiffany J. Glass, Troy C. Lund, Xiaobai Patrinostro, Jakub Tolar, Teresa V. Bowman, Leonard I. Zon, Bruce R. Blazar

Blood (2011) 118 (3): 766–774.

https://doi.org/10.1182/blood-2011-01-328476

Published: 2011

Includes: Supplemental data

Journal Articles

Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)

Jakub Tolar, In-Hyun Park, Lily Xia, Chris J. Lees, Brandon Peacock, Beau Webber, Ron T. McElmurry, Cindy R. Eide, Paul J. Orchard, Michael Kyba, Mark J. Osborn, Troy C. Lund, John E. Wagner, George Q. Daley, Bruce R. Blazar

Blood (2011) 117 (3): 839–847.

https://doi.org/10.1182/blood-2010-05-287607

Published: 2011

Includes: Supplemental data

Journal Articles

G-CSF Mobilized Human Mesenchymal Stem Cells Are Found in the Peripheral Blood and Have Telomere Limited Growth Potential.

Troy C. Lund, MD, PhD, Lisa Baso, Paul J. Orchard, MD

Blood (2006) 108 (11): 4246.

https://doi.org/10.1182/blood.V108.11.4246.4246

Published: 2006

NARROW

First Documentation of Cell-to-Cell Peroxisome Transfer in Hematopoietic Stem and Progenitor Cells: A Method to "Relieve Stress"?

Bodyweight and Absolute Lymphocyte Count Based Dosing of Rabbit Anti-Thymocyte Globulin Results in Early CD4+ Immune Reconstitution in Patients with Inborn Errors of Metabolism Undergoing Umbilical Cord Blood Transplantation

Adrenoleukodystrophy Protein (ALDP) Antibody Formation and Graft Loss in Gene Therapy for Adrenoleukodystrophy

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in Gvhd Risk without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

Low Incidence of Chronic Graft-Versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Using Matched Related or Unrelated Donors: Phase II Study Interim Analysis

Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy

Preliminary Phase 2 Results Demonstrate Engraftment with Minimal Neutropenia with MGTA-456, a CD34 + Expanded Cord Blood (CB) Product in Patients Transplanted for Inherited Metabolic Disorders (IMD)

Repair of the Blood Brain Barrier and Neutrophil Recovery Following HSCT in Cerebral Adrenoleukodystrophy

HHV-6 Prophylaxis with Foscanet Improves Hematopoietic Engraftment after Umbilical Cord Blood Transplantation

Pediatric multiple myeloma

Adipogenic Chemokine Inhibition of Hematopoietic Cell Adherence and Transmigration, a Hurdle to Homing

Mitochondrial Haplotype As an Independent Predictor of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT)

Mutant tp53 Causes a Gain of Function Increase in Sensitivity to Reactive Oxygen Species in Erythroid Precursors

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33 + targets

The Oxidative Stress Response In Erythroid Precursors Is Mediated By tp53

A Novel CD16xCD33 Bispecific Killer Cell Engager (BiKE) Mediates a Double Hit For Natural Killer (NK) Cells To Target CD33 + Myelodysplastic Syndrome (MDS) Cells and Myeloid Derived Suppressor Cells (MDSCs) At All Disease Stages

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report

Stromal cell–derived factor-1 and hematopoietic cell homing in an adult zebrafish model of hematopoietic cell transplantation

Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)

G-CSF Mobilized Human Mesenchymal Stem Cells Are Found in the Peripheral Blood and Have Telomere Limited Growth Potential.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only